Double maintains 2 strategies that include TGTX - TG Therapeutics, Inc.
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
GBTG | 39.29% | $2.91B | +0.33% | 0.00% |
ALT | 38.62% | $468.80M | -35.06% | 0.00% |
KYMR | 36.59% | $1.95B | -15.67% | 0.00% |
ROIV | 35.86% | $7.68B | -5.70% | 0.00% |
ZWS | 34.98% | $6.23B | +14.37% | 0.92% |
ACLX | 34.47% | $3.22B | +10.72% | 0.00% |
TRS | 34.25% | $1.01B | -11.04% | 0.65% |
DAVE | 33.78% | $2.45B | +268.07% | 0.00% |
OFIX | 33.52% | $478.01M | -19.26% | 0.00% |
AVXL | 33.14% | $714.56M | +86.00% | 0.00% |
LGND | 32.71% | $2.00B | +21.70% | 0.00% |
AUPH | 32.51% | $1.10B | +41.25% | 0.00% |
RKLB | 32.24% | $11.64B | +494.81% | 0.00% |
VMEO | 32.12% | $777.59M | +16.54% | 0.00% |
MGTX | 31.93% | $405.04M | -11.27% | 0.00% |
CBT | 31.89% | $4.05B | -25.77% | 2.29% |
KNF | 31.78% | $5.65B | +33.23% | 0.00% |
KRYS | 31.78% | $3.77B | -20.42% | 0.00% |
CPRX | 31.74% | $2.90B | +45.00% | 0.00% |
SFBS | 31.58% | $4.26B | +19.50% | 1.63% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -31.68% | $109.64M | 0.85% |
TAIL | -22.80% | $140.49M | 0.59% |
BTAL | -14.79% | $361.41M | 1.43% |
UGA | -11.61% | $73.47M | 0.97% |
DBO | -10.44% | $182.54M | 0.77% |
USL | -9.71% | $41.76M | 0.85% |
BNO | -9.62% | $86.13M | 1% |
ULST | -9.27% | $637.77M | 0.2% |
OILK | -9.26% | $63.21M | 0.69% |
WEAT | -9.15% | $115.83M | 0.28% |
DBE | -8.90% | $48.48M | 0.77% |
USO | -8.78% | $956.18M | 0.6% |
COMT | -8.33% | $606.15M | 0.48% |
DBC | -8.21% | $1.17B | 0.87% |
XBIL | -8.06% | $782.40M | 0.15% |
PDBC | -7.90% | $4.43B | 0.59% |
FXY | -7.88% | $838.61M | 0.4% |
TPMN | -7.85% | $31.54M | 0.65% |
CANE | -7.57% | $10.71M | 0.29% |
GSG | -5.88% | $917.54M | 0.75% |
Yahoo
We recently published a list of 10 Best Cancer Stocks to Invest in for Long-Term Gains. In this article, we are going to take a look at where TG Therapeutics, Inc. (NASDAQ:TGTX) stands against other best cancer stocks to invest in for long-term gain. Surging Cancer Cases and Costs Drive Growth in the Global Oncology […]
SeekingAlpha
Biotech ETFs face sharp declines, but strong operational momentum in select companies offers investment opportunities.
Yahoo
TG Therapeutics ( NASDAQ:TGTX ) First Quarter 2025 Results Key Financial Results Revenue: US$120.9m (up 90% from 1Q...
Yahoo
TG Therapeutics Inc (TGTX) reports impressive growth in BRIUMVI sales and raises its full-year revenue outlook, despite facing competitive market challenges.
Yahoo
Q1 2025 TG Therapeutics Inc Earnings Call
Yahoo
A huge miss on the bottom line drove investors away from the shares. The company, best known for its multiple sclerosis (MS) drug Briumvi, posted its first-quarter results that morning, and investors expressed their displeasure by trading out of the stock aggressively. TG's revenue is comprised almost entirely of Briumvi sales, so when those sales improve so does the company's revenue line.
Current Value
$33.651 Year Return
Current Value
$33.651 Year Return
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
VHC | <0.01% | $34.69M | +74.89% | 0.00% |
HIHO | -0.04% | $8.25M | -10.29% | 3.73% |
CEF.U | 0.17% | - | - | 0.00% |
UEC | -0.27% | $2.41B | -19.48% | 0.00% |
SDRL | 0.29% | $1.71B | -52.71% | 0.00% |
DAR | 0.30% | $5.59B | -20.01% | 0.00% |
SRDX | -0.32% | $400.81M | -17.75% | 0.00% |
AMR | -0.42% | $1.59B | -57.99% | 0.00% |
JRVR | -0.47% | $217.53M | -41.34% | 2.55% |
KOS | -0.56% | $836.52M | -70.29% | 0.00% |
CYD | -0.56% | $643.06M | +106.88% | 2.24% |
DG | 0.60% | $20.45B | -36.56% | 2.55% |
NEXT | -0.61% | $2.01B | +8.30% | 0.00% |
BTU | 0.66% | $1.74B | -36.57% | 2.62% |
MOMO | 0.66% | $768.25M | +8.00% | 0.00% |
UEIC | 0.68% | $96.27M | -39.08% | 0.00% |
BG | 0.78% | $10.76B | -23.23% | 3.40% |
GHI | 0.79% | $272.58M | -23.91% | 12.67% |
LU | 0.81% | $2.45B | -35.82% | 0.00% |
PLG | 0.91% | $115.89M | -32.32% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
IMMP | -12.51% | $289.16M | -32.19% | 0.00% |
NEUE | -11.78% | $62.05M | +13.56% | 0.00% |
STG | -10.76% | $27.05M | -37.35% | 0.00% |
LITB | -10.65% | $21.28M | -72.45% | 0.00% |
K | -9.40% | $28.49B | +32.17% | 2.77% |
ZCMD | -9.27% | $32.45M | -11.38% | 0.00% |
VSA | -9.15% | $7.04M | -49.24% | 0.00% |
NABL | -7.46% | $1.54B | -36.63% | 0.00% |
SYPR | -7.09% | $37.69M | +21.48% | 0.00% |
CIG.C | -6.87% | $2.45B | +9.77% | 0.00% |
CPSH | -6.67% | $27.45M | +8.62% | 0.00% |
JMIA | -6.44% | $374.74M | -54.05% | 0.00% |
HUSA | -6.41% | $9.73M | -55.71% | 0.00% |
CARV | -6.33% | $7.41M | -22.87% | 0.00% |
FMTO | -6.29% | $45.74M | -99.96% | 0.00% |
GORV | -6.15% | $15.42M | -96.17% | 0.00% |
CBOE | -5.92% | $22.95B | +20.67% | 1.12% |
NOVA | -5.52% | $27.46M | -95.24% | 0.00% |
FUBO | -5.09% | $1.01B | +121.80% | 0.00% |
BVN | -5.07% | $3.68B | -15.25% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
PBE | 45.82% | $214.12M | 0.58% |
XBI | 43.57% | $4.85B | 0.35% |
PTH | 41.87% | $96.56M | 0.6% |
BTC | 41.87% | $4.48B | 0.15% |
IBB | 39.25% | $5.22B | 0.45% |
BBH | 37.72% | $327.42M | 0.35% |
FBT | 37.28% | $994.71M | 0.56% |
SMMV | 35.90% | $305.76M | 0.2% |
IWO | 34.52% | $11.36B | 0.24% |
XPH | 34.49% | $136.58M | 0.35% |
IWC | 34.14% | $766.88M | 0.6% |
CLOU | 34.01% | $363.83M | 0.68% |
FIW | 33.79% | $1.82B | 0.53% |
GNOM | 33.73% | $40.65M | 0.5% |
XMLV | 33.49% | $819.68M | 0.25% |
VTWO | 33.46% | $12.07B | 0.07% |
IWM | 33.40% | $63.95B | 0.19% |
GSSC | 33.36% | $538.65M | 0.2% |
USMF | 33.18% | $388.34M | 0.28% |
KJUL | 32.99% | $113.35M | 0.79% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
IVOL | -0.03% | $353.94M | 1.02% |
XHLF | -0.04% | $1.46B | 0.03% |
UDN | 0.14% | $137.74M | 0.78% |
STPZ | -0.22% | $446.46M | 0.2% |
EWH | -0.24% | $616.70M | 0.5% |
IBMN | 0.30% | $446.12M | 0.18% |
KMLM | 0.38% | $188.32M | 0.9% |
CTA | -0.47% | $1.05B | 0.76% |
COM | 0.60% | $222.08M | 0.72% |
FMF | -0.63% | $153.73M | 0.95% |
BWX | 0.69% | $1.41B | 0.35% |
XONE | -0.74% | $603.24M | 0.03% |
GLTR | 0.77% | $1.33B | 0.6% |
ASHR | -0.87% | $1.95B | 0.65% |
KBA | -0.93% | $175.37M | 0.56% |
CPER | -0.96% | $163.44M | 0.97% |
BILS | -0.99% | $3.96B | 0.1356% |
CMDY | -1.01% | $258.39M | 0.28% |
LDUR | 1.02% | $849.09M | 0.5% |
FXE | 1.13% | $525.40M | 0.4% |